Relationship Between TNF-α and the Risk of Cerebral Palsy: A Systematic Review and Meta-Analysis

Baotian Wang1, Fan Wang1, De Wu1

  • 1Department of Pediatrics, First Affiliated Hospital of Anhui Medical University, Hefei, China.

Insights

Elevated blood tumor necrosis factor-alpha (TNF-α) levels are linked to a higher risk of cerebral palsy (CP) in children. Further research is needed to understand this association.

Area of Science:

  • Biomedical Science
  • Neuroscience
  • Immunology

Background:

  • Cerebral palsy (CP) is a complex neurological disorder with multifactorial causes.
  • Inflammation, particularly involving cytokines like tumor necrosis factor-alpha (TNF-α), is increasingly recognized as a potential contributor to CP pathogenesis.

Approach:

  • A comprehensive meta-analysis was conducted, synthesizing data from nine observational studies.
  • Studies were systematically searched across major databases (PubMed, Web of Science, Cochrane Library, Ovid) up to April 2022.
  • Statistical methods, including a random-effects model and heterogeneity analysis, were employed to assess the association between blood TNF-α levels and CP risk.

Key Points:

  • The meta-analysis included 1,117 cases and 3,563 controls, with good literature quality and no significant publication bias.
  • Elevated blood TNF-α levels demonstrated a statistically significant association with an increased risk of cerebral palsy (Odds Ratio: 1.82, 95% CI: 1.25-2.66).
  • Substantial heterogeneity was observed among the included studies (I² = 81.2%, p = 0.000), indicating variability in findings.

Conclusions:

  • This meta-analysis provides evidence that higher blood levels of TNF-α are associated with an elevated risk of developing cerebral palsy in children.
  • The findings underscore the potential role of TNF-α in CP development.
  • Further investigation is warranted to elucidate the precise mechanisms underlying the TNF-α and CP association and its clinical implications.
Abstract